Evidence map›Paper›PMID 34200897›Full record

SynthesisNutrients2021

Polysaccharides with Antitumor Effect in Breast Cancer: A Systematic Review of Non-Clinical Studies.

Claudia Rita Corso, Natalia Mulinari Turin de Oliveira, Leonardo Moura Cordeiro, Karien Sauruk da Silva, Suzany Hellen da Silva Soczek, Virgilio Frota Rossato, Elizabeth Soares Fernandes, Daniele Maria-Ferreira

Abstract readSystematic Review
In one paragraph

Synthesis in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Anti-Cancer Potential of Linear β-(1→6)-D-Glucan fromMolecules (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Glucan fromJournal of Cancer · 2024
    Article
  8. Review
  9. Article
  10. Ginseng polysaccharides: Potential antitumor agents.Journal of ginseng research · 2023
    Review
  11. Chemical Evaluation ofMolecules (Basel, Switzerland) · 2023
    Article
  12. Review
  13. A novel anticancer property ofJournal of Zhejiang University. Science. B · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Claudia Rita CorsoInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.ORCID 0000-0001-6594-3542
Natalia Mulinari Turin de OliveiraInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
Leonardo Moura CordeiroInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
Karien Sauruk da SilvaInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
Suzany Hellen da Silva SoczekInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
Virgilio Frota RossatoInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.ORCID 0000-0001-5087-4230
Elizabeth Soares FernandesInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.ORCID 0000-0002-0567-2514
Daniele Maria-FerreiraInstituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.ORCID 0000-0001-7992-510X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic AgentsBreast NeoplasmsFemaleHumansPolysaccharidesPublication BiasRiskAntineoplastic AgentsPolysaccharidesbreast cancercancer treatmentnatural sourcenonclinical studiespolysaccharides

Identifiers

PMID34200897
PMCPMC8230509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.